(5S)-5-(((TETRAHYDRO-2H-PYRAN-2-YL)OXY)METHYL)DIHYDROFURAN-2(3H)-ONE, 95.0%, 250mg

(R)-4-Amino-4-phenylbutanoic acid hydrochloride, 95.0%, 250mg

Bis(1,5-cyclooctadiene)diiridium(I) dichloride, 98.0%, 500mg

4-Bromo-3-hydroxybenzoic acid, 97.0%, 1g

N-[(BENZYLOXY)CARBONYL]-D-NORVALINE, 95.0%, 25g

N-Butyl-4-nitroaniline, 95.0%, 5g

1-Heptanol, min. 99%, for synthesis, 500 ml, glass packaging

TIOCONAZOLE, 95%, 100mg

tert-Butyl 7,9-dioxo-2,6-diazaspiro[3.5]nonane-2-carboxylate, 95.0%, 500mg

Potassium oxalate monohydrate, 98.5%, 250g

4-(6-Methyl-1,2,4,5-tetrazin-3-yl)phenol, 98%, 1g

2,2,2-Trifluoroacetic acid compound with 7-azaspiro[3.5]nonane-2-carboxylic acid (1:1), 98%, 250mg

3-Iodo-5-methyl-1H-pyrazole, 95.0%, 1g